Chengdu, China

Jia Ni

This inventor holds 1 USPTO granted patent. Top assignee: Xizang Haisco Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia Ni. Retrieved from https://idiyas.com/inventor/jia-ni-krzn080d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jia Ni

Introduction: Jia Ni is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of medicine through his innovative research and development. His work focuses on the creation of novel compounds that have potential therapeutic applications.

Latest Patents: Jia Ni holds a patent for a compound described as a benzo nitrogen-containing heteroaromatic ring derivative. This compound is detailed in the general formula (I) and includes various forms such as stereoisomers, deuterates, solvates, prodrugs, metabolites, pharmaceutically acceptable salts, or co-crystals. The patent outlines its use in the preparation of drugs aimed at treating diseases associated with the activity or expression quantity of complement factor B. He has 1 patent to his name.

Career Highlights: Jia Ni is currently employed at Xizang Haisco Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on drug development and therapeutic strategies.

Collaborations: Jia Ni collaborates with talented colleagues, including Chen Zhang and Yuting Liao, who contribute to his research endeavors and help drive innovation within their projects.

Conclusion: Jia Ni's contributions to the field of medicine through his innovative patents and collaborative efforts highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…